Eagle Pharmaceuticals to Present at the 41st Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) announced that CEO Scott Tarriff and CFO Brian Cahill will present at the 41st Annual J.P. Morgan Healthcare Conference on January 10, 2023, at 10:30 AM PT/1:30 PM ET. The presentation will be available as a webcast for 30 days on the company’s website, allowing investors to access key insights into Eagle’s corporate strategies and product pipeline. The company is recognized for its innovative pharmaceutical solutions aimed at improving patient outcomes, with commercialized products across critical care and oncology.

WOODCLIFF LAKE, N.J., Dec. 21, 2022 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle” or the “Company”) today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present at the 41^st Annual J.P. Morgan Healthcare Conference as follows:

Date:	Tuesday, January 10, 2023
Time:	10:30AM PT/1:30PM ET
Webcast:	Click Here

The webcast of the presentation will be accessible for 30 days thereafter, via the Company’s website at www.eagleus.com, under the Investors section.

About Eagle Pharmaceuticals, Inc.
Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients’ lives. Eagle’s commercialized products include vasopressin, PEMFEXY®, RYANODEX®, BENDEKA®, BELRAPZO®, TREAKISYM® (Japan), and BYFAVO® and BARHEMSYS® through its wholly owned subsidiary Acacia Pharma Inc. Eagle’s oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle’s website at www.eagleus.com.

Investor Relations for Eagle Pharmaceuticals, Inc.:
Lisa M. Wilson
In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

FAQ

When will Eagle Pharmaceuticals present at the J.P. Morgan Healthcare Conference?

Eagle Pharmaceuticals will present on January 10, 2023.

What time will Eagle Pharmaceuticals' presentation start?

The presentation will start at 10:30 AM PT / 1:30 PM ET.

How can I access the Eagle Pharmaceuticals conference presentation?

The conference presentation can be accessed via a webcast link available on Eagle Pharmaceuticals' website.

Who will represent Eagle Pharmaceuticals at the J.P. Morgan Healthcare Conference?

Scott Tarriff, CEO, and Brian Cahill, CFO, will represent the company.

What is the stock symbol for Eagle Pharmaceuticals?

The stock symbol for Eagle Pharmaceuticals is EGRX.